2019

2019

Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)

Admin6 November 2019

Peter R. Rehani,1 Hanaa Iftikhar,2 Motowo Nakajima,3 Tohru Tanaka,3 Zaid Jabbar,4 and Riyadh N. Rehani5 Conclusion: The provided analysis of the different mechanisms of action of ... Read More

Announced the results of joint research on the development of a treatment for mitochondrial disease using 5-aminolevulinic acid and sodium ferrous citrate

Admin9 August 2019

SBI Pharma Co., Ltd. Saitama Medical University Chiba Children’s Hospital Juntendo University SBI Pharma Co., Ltd. (Location: Minato-ku, Tokyo, President: ... Read More

2019

Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)

Announced the results of joint research on the development of a treatment for mitochondrial disease using 5-aminolevulinic acid and sodium ferrous citrate

Make an enquiry